Stratec SE

XETRA SBS.DE

Stratec SE Current Liabilities for the year ending December 31, 2023: USD 106.43 M

Stratec SE Current Liabilities is USD 106.43 M for the year ending December 31, 2023, a 65.12% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Stratec SE Current Liabilities for the year ending December 31, 2022 was USD 64.46 M, a 24.00% change year over year.
Stratec SE Current Liabilities for the year ending December 31, 2021 was USD 51.99 M, a 19.32% change year over year.
Stratec SE Current Liabilities for the year ending December 31, 2020 was USD 43.57 M, a 8.84% change year over year.
Stratec SE Current Liabilities for the year ending December 31, 2019 was USD 40.03 M, a -10.42% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

XETRA: SBS.DE

Stratec SE

CEO	Mr. Marcus Wolfinger
IPO Date	June 16, 2000
Location	Germany
Headquarters	Gewerbestrasse 37
Employees	1,462
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Defense & Military Hardware & Electronics Personal Care Plastics Robotics

Description

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Key trends

Past 5 years